1206800-25-0

Basic information

• Product Name: 2,4-dibromo-5-(2-fluoro-4-nitrophenoxy) benzaldehyde
• Synonyms: 2,4-dibromo-5-(2-fluoro-4-nitrophenoxy) benzaldehyde
• CAS NO: 1206800-25-0
• Molecular Weight: 419.001
• Mol File: 1206800-25-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,4-dibromo-5-(2-fluoro-4-nitrophenoxy) benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-dibromo-5-(2-fluoro-4-nitrophenoxy) benzaldehyde(1206800-25-0)
• EPA Substance Registry System: 2,4-dibromo-5-(2-fluoro-4-nitrophenoxy) benzaldehyde(1206800-25-0)

Safety Data

• Hazardous Substances Data: 1206800-25-0(Hazardous Substances Data)

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 369-34-6 3,4-difluoronitrobenzene 
• 3111-51-1 2,4-dibromo-5-hydroxybenzaldehyde 

Downstream Products

• 1206800-26-1 1-(2,4-dibromo-5-(2-fluoro-4-nitrophenoxy)benzylidene)-2-methylhydrazine 
• 1206799-15-6 N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1206800-42-1 tert-butyl 4-(5-(2-fluoro-4-nitrophenoxy)-1-methyl-1H-indazol-6-yl)-1H-pyrazole-1-carboxylate 
• 1206800-56-7 tert-butyl 4-(5-(4-amino-2-fluorophenoxy)-1-methyl-1H-indazol-6-yl)-1H-pyrazole-1-carboxylate 
• 1206801-36-6 tert-butyl 4-(5-(2-fluoro-4-(1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamido)phenoxy)-1-methyl-1H-indazol-6-yl)-1H-pyrazole-1-carboxylate 
• 1206800-24-9 6-bromo-5-(2-fluoro-4-nitrophenoxy)-1-methyl-1H-indazole 
• 1206800-67-0 3-fluoro-4-(1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yloxy)aniline 
• 1577180-07-4 N-(4-((6-bromo-1-methyl-1H-indazol-5-yl)oxy)-3-fluorophenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1206800-43-2 5-(2-Fluoro-4-nitrophenoxy)-1-methyl-6-(1 H-pyrazol-4-yl)-1H-indazole 

Relevant articles and documents

TRK INHIBITOR AS ANTI-CANCER DRUG

The present disclosure relates to a group of tropomyosin receptor kinase inhibitors comprising an amido-phenoxy-indazole structure fragment. These compounds show potent inhibitory effects on various oncogenic kinases, especially TRK, and thus can be used

AMIDOPHENOXYINDAZOLES USEFUL AS INHIBITORS OF C-MET

The present invention provides amidophenoxyindazole compounds useful in the treatment of cancer.